soul trial oral semaglutide cardiovascular outcomes nejm 2025 results in High-Risk Type 2 Diabetes: Benefit Confirmed in the SOUL: Oral Semaglutide Bests Usual
Description
Real results, real doctors
Compounded in small doses, often chosen for balance and daily support.
OR: 2.1
Guidance on sick day management for type 1 diabetes during intercurrent illness, covering monitoring, hydration, carbohydrate intake, insulin adjustments, and when to seek care.
Your doctor will want to see you regularly to assess how well your medications are working and whether any changes are needed.
Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to a new RANDreport
